A practical guide to tracking GHK-Cu protocols — what to measure, what to photograph, and what the realistic timelines look like.
At a glance
GHK-Cu (copper tripeptide-1) sits in a different category than BPC-157 or TB-500. The interesting effects are largely visible: skin, hair, wound healing. That changes how you track it.
GHK-Cu is a naturally occurring copper-binding tripeptide. Levels decline with age. It has been studied for skin appearance, wound healing, and hair-related effects, with most published work in cell models and topical formulations. Injectable use in self-experimenters is more recent and less well-studied.
Two main routes show up in self-reports:
This post focuses on tracking, not endorsing either route.
This is where GHK-Cu protocols are different from a BPC-157 or TB-500 cycle. You can see the result, which means photos are mandatory.
Stack them in Peptide IA's progress journal. After 8 weeks, scroll through them. Subtle changes that you would miss day-to-day become obvious in a side-by-side.
Visible changes in skin and hair are slow. Self-reports cluster around:
If you stop at week 3 because "nothing happened," you did not give the protocol time to show. This is why tracking from day 0 matters — if you log faithfully and there is still no change at week 8, that is real data.
If you use both injectable and topical GHK-Cu, log them separately. They have different absorption profiles and different effect locations.
GHK-Cu is unusually well-suited to honest tracking because the outcomes are visible. Photographs, weekly cadence, consistent conditions, and no other interventions during the cycle. Do that, and at week 8 you will know whether it worked for you — which is the only data point that matters.
Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.